News

“Bonjour Tristesse” is set in the present day but pulls from vintage aesthetics. It “exists out of time” and taps into a ...
But alongside their director, Sevigny and McInerny carefully remind us that fantasy and tragedy are interlinked. Chew-Bose’s ...
Eli Lilly stock has been a big-time winner over the last couple of years, but looming tariffs are worrying some investors. The pharmaceutical sector could be the next industry to face sweeping ...
In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best low volatility stocks to buy now. The US stock market experienced a turbulent first ...
"Be mindful about what you're sharing, because once it's online, it's online forever," says Lilly Sabri. The fitness influencer, who has six million followers on YouTube, has urged fans to heed ...
The real-life story of Natalia Grace continues to unfold, with new revelations about her adoption, guardianship, and complicated family relationships. Scottish journalist and lifelong sports fan ...
The first GLP-1 weight-loss pill is a step closer to hitting the market. Eli Lilly said its experimental pill met its goals in a pivotal study, helping diabetes patients lower blood sugar—and ...
Eli Lilly and Company, which already markets weight-loss and diabetes drugs that must be injected, is a step closer to introducing a once-daily pill for the same conditions. On April 17 ...
You can get in touch with Jenna by emailing [email protected]. Languages: English Natalia Grace is again the subject of public conversation following new allegations she shared about her time ...
It's Thursday morning, 11:50 a.m. ET -- and Eli Lilly (NYSE: LLY) stock is off to the races! This morning, the Indianapolis-based pharmaceutical giant announced that its new GLP-1 weight loss pill ...
Drugmaker Eli Lilly said the first trial showed similar weight loss and diabetes management results when compared to the pill’s injectable counterparts. About 1 in 8 adults in the U.S. has taken ...